While endothelial NOS (eNOS) and the vasodilatory properties of nitric oxide are well known to influence pulmonary hypertension [89], only recently has it been demonstrated that myelocytic NOS expression may be necessary in order to prevent pulmonary hypertension in a murine chronic-hypoxia model [90]. The gene discussed is NOS3; the disease is pulmonary arterial hypertension.